Cannabis Sativa (CBDS) Stock Price, News & Analysis

Company Overview

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.02 to $0.03
• 52-Week Range: $0.00 to $0.17
• Volume: 182,844 shs
• Average Volume: 1.07 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Cannabis Sativa Stock Analysis - MarketRank™

Cannabis Sativa scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cannabis Sativa.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Cannabis Sativa is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cannabis Sativa is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cannabis Sativa has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cannabis Sativa has recently decreased by 70.31%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cannabis Sativa does not currently pay a dividend.

Dividend Growth

Cannabis Sativa does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cannabis Sativa has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cannabis Sativa has recently decreased by 70.31%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Cannabis Sativa this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cannabis Sativa insiders have not sold or bought any company stock.

Percentage Held by Insiders

27.46% of the stock of Cannabis Sativa is held by insiders. A high percentage of insider ownership can be a sign of company health.

CBDS Stock Analysis - Frequently Asked Questions

How have CBDS shares performed this year?

Cannabis Sativa's stock was trading at $0.0870 at the beginning of the year. Since then, CBDS shares have decreased by 69.1% and is now trading at $0.0269.

How do I buy shares of Cannabis Sativa?

Shares of CBDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cannabis Sativa own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cannabis Sativa investors own include Canopy Growth (CGC), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Cara Therapeutics (CARA), 22nd Century Group (XXII) and Sangamo Therapeutics (SGMO).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:CBDS
• CIK: 1360442
• Web: www.cannabissativainc.com
• Phone: (702) 762-3123
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A